อ้างอิง ของ อะคาร์โบส

  1. ↑ "International Nonproprietary Names for Pharmaceutical Substances. Recommended International Nonproprietary Names (Rec. INN): List 19" (PDF). World Health Organization. 1979. สืบค้นเมื่อ 9 November 2016.
  2. ↑ Kresge N (21 November 2011). "China's Thirst for New Diabetes Drugs Threatens Bayer's Lead". Bloomberg Business Week. คลังข้อมูลเก่า เก็บจาก แหล่งเดิม เมื่อ 21 November 2011. สืบค้นเมื่อ 15 April 2016.
  3. ↑ Zhang W, Kim D, Philip E, Miyan Z, Barykina I, Schmidt B, Stein H (April 2013). "A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study". Clinical Drug Investigation. 33 (4): 263–74. doi:10.1007/s40261-013-0063-3. PMID 23435929. S2CID 207483590.
  4. ↑ Zhu Q, Tong Y, Wu T, Li J, Tong N (June 2013). "Comparison of the hypoglycemic effect of acarbose monotherapy in patients with type 2 diabetes mellitus consuming an Eastern or Western diet: a systematic meta-analysis". Clinical Therapeutics. 35 (6): 880–99. doi:10.1016/j.clinthera.2013.03.020. PMID 23602502.

แหล่งที่มา

WikiPedia: อะคาร์โบส http://www.businessweek.com/news/2011-11-21/china-... http://www.chemspider.com/Chemical-Structure.39223... //pubmed.ncbi.nlm.nih.gov/23435929 //pubmed.ncbi.nlm.nih.gov/23602502 http://www.who.int/medicines/publications/druginfo... http://www.kegg.jp/entry/D00216 http://www.yaandyou.net/index_list.php?drugname=Pr... http://www.commonchemistry.org/ChemicalDetail.aspx... //doi.org/10.1007%2Fs40261-013-0063-3 //doi.org/10.1016%2Fj.clinthera.2013.03.020